Can Lurbinectedin be controlled for 18 months?

Lurbinectedin (Lurbinectedin) can control the progression of cancer for 18 months or longer in some cases. However, the effectiveness of treatment varies depending on the patient's specific condition, cancer type and other factors and cannot be generalized. The following is a detailed description of rubicartin's control of cancer for 18 months:

1.Individual differences: Cancer is a highly individualized disease, and different patients' responses to treatment drugs will vary greatly. Some patients may have a strong therapeutic response to rubicatin, slowing the progression of their cancer and maintaining a stable state during treatment.

2.Efficacy evaluation: The efficacy of rubicatin is usually evaluated by progression-free survival (Progression-Free Survival, PFS), which refers to the time interval from the start of treatment to disease progression or death. In some clinical trials, PFS was longer in the rubicatin treatment group, reaching or exceeding 18 months. This means that some patients are able to maintain a stable disease state for a relatively long period of time after receiving rubicartin.

3.Effect maintenance: The efficacy of rubicatin is not only reflected in the prolongation of PFS, but may also affect overall survival (Overall Survival, OS). Some studies have shown that overall survival may also be improved in the rubicatin-treated group at mid-treatment, although the difference may not be very significant.

4.Treatment plan: The treatment plan for rubicatin is usually formulated by a doctor based on the patient's specific situation and cancer type. Treatment may be a single drug or may be combined with other drugs or treatments to increase effectiveness.

Rubicardin has not yet been launched in China, so it is not included in medical insurance. Patients cannot purchase it domestically and need to purchase Rubicatin through overseas channels. There is only the original drug Rubicatin in foreign countries, and the price is relatively expensive. In comparison, the original drug in Singapore is slightly cheaper, priced at more than 30,000, and there are other American versions of the original drug, priced at more than 90,000.